703 related articles for article (PubMed ID: 27601222)
21. CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection.
Freeman ML; Mudd JC; Shive CL; Younes SA; Panigrahi S; Sieg SF; Lee SA; Hunt PW; Calabrese LH; Gianella S; Rodriguez B; Lederman MM
Clin Infect Dis; 2016 Feb; 62(3):392-6. PubMed ID: 26400999
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for pediatric human immunodeficiency virus-related malignancy.
Pollock BH; Jenson HB; Leach CT; McClain KL; Hutchison RE; Garzarella L; Joshi VV; Parmley RT; Murphy SB
JAMA; 2003 May; 289(18):2393-9. PubMed ID: 12746363
[TBL] [Abstract][Full Text] [Related]
24. Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group.
Lang DJ; Kovacs AA; Zaia JA; Doelkin G; Niland JC; Aledort L; Azen SP; Fletcher MA; Gauderman J; Gjerset GJ
J Acquir Immune Defic Syndr (1988); 1989; 2(6):540-9. PubMed ID: 2555471
[TBL] [Abstract][Full Text] [Related]
25. Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.
Henrich TJ; Hobbs KS; Hanhauser E; Scully E; Hogan LE; Robles YP; Leadabrand KS; Marty FM; Palmer CD; Jost S; Körner C; Li JZ; Gandhi RT; Hamdan A; Abramson J; LaCasce AS; Kuritzkes DR
J Infect Dis; 2017 Jul; 216(2):254-262. PubMed ID: 28838149
[TBL] [Abstract][Full Text] [Related]
26. Proximity of Cytomegalovirus-Specific CD8
Heath JJ; Fudge NJ; Gallant ME; Grant MD
Front Immunol; 2018; 9():201. PubMed ID: 29527205
[TBL] [Abstract][Full Text] [Related]
27. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV.
Boutboul F; Puthier D; Appay V; Pellé O; Ait-Mohand H; Combadière B; Carcelain G; Katlama C; Rowland-Jones SL; Debré P; Nguyen C; Autran B
AIDS; 2005 Nov; 19(17):1981-6. PubMed ID: 16260904
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
29. Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.
Freeman ML; Lederman MM; Gianella S
Curr HIV/AIDS Rep; 2016 Feb; 13(1):10-9. PubMed ID: 26810437
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.
Ling PD; Vilchez RA; Keitel WA; Poston DG; Peng RS; White ZS; Visnegarwala F; Lewis DE; Butel JS
Clin Infect Dis; 2003 Nov; 37(9):1244-9. PubMed ID: 14557970
[TBL] [Abstract][Full Text] [Related]
31. Comparing the sub-gingival levels of Cytomegalovirus, Epstein-Barr virus, Porphyromonas gingivalis in human immunodeficiency virus-1 seropositive patients with and without antiretroviral therapy.
Kheur S; Kulkarni M; Mahajan PG; Kheur M; Raj AT; Patil S; Awan KH
Dis Mon; 2021 Sep; 67(9):101166. PubMed ID: 33663798
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy.
Righetti E; Ballon G; Ometto L; Cattelan AM; Menin C; Zanchetta M; Chieco-Bianchi L; De Rossi A
AIDS; 2002 Jan; 16(1):63-73. PubMed ID: 11741164
[TBL] [Abstract][Full Text] [Related]
33. Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.
Hunt PW; Martin JN; Sinclair E; Epling L; Teague J; Jacobson MA; Tracy RP; Corey L; Deeks SG
J Infect Dis; 2011 May; 203(10):1474-83. PubMed ID: 21502083
[TBL] [Abstract][Full Text] [Related]
34. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology.
Stevens SJ; Blank BS; Smits PH; Meenhorst PL; Middeldorp JM
AIDS; 2002 May; 16(7):993-1001. PubMed ID: 11953465
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of the plasma load of cytomegalovirus in patients infected with HIV--a survival analysis.
Aramă V; Mihăilescu R; Rădulescu M; Aramă SŞ; Streinu-Cercel A; Youle M;
J Med Virol; 2014 Nov; 86(11):1821-7. PubMed ID: 25087866
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
37. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
38. Cross-sectional study of CD4: CD8 ratio recovery in young adults with perinatally acquired HIV-1 infection.
Pollock KM; Pintilie H; Foster C; Fidler S
Medicine (Baltimore); 2018 Feb; 97(8):e9798. PubMed ID: 29465561
[TBL] [Abstract][Full Text] [Related]
39. Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients.
Ammatuna P; Campisi G; Giovannelli L; Giambelluca D; Alaimo C; Mancuso S; Margiotta V
Oral Dis; 2001 Jan; 7(1):34-40. PubMed ID: 11354920
[TBL] [Abstract][Full Text] [Related]
40. Cytomegalovirus rather than HIV triggers the outgrowth of effector CD8+CD45RA+CD27- T cells in HIV-1-infected children.
Bekker V; Bronke C; Scherpbier HJ; Weel JF; Jurriaans S; Wertheim-van Dillen PM; van Leth F; Lange JM; Tesselaar K; van Baarle D; Kuijpers TW
AIDS; 2005 Jul; 19(10):1025-34. PubMed ID: 15958833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
